(Q36141019)

English

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3. (English)

1 reference

Europe PubMed Central

12 August 2017

author name string

Molina R

1

1 reference

Europe PubMed Central

12 August 2017

Jo J

2

1 reference

Europe PubMed Central

12 August 2017

Zanón G

3

1 reference

Europe PubMed Central

12 August 2017

Filella X

4

1 reference

Europe PubMed Central

12 August 2017

Farrus B

5

1 reference

Europe PubMed Central

12 August 2017

Muñoz M

6

1 reference

Europe PubMed Central

12 August 2017

Latre ML

7

1 reference

Europe PubMed Central

12 August 2017

Pahisa J

8

1 reference

Europe PubMed Central

12 August 2017

Velasco M

9

1 reference

Europe PubMed Central

12 August 2017

Fernandez P

10

1 reference

Europe PubMed Central

12 August 2017

Estapé J

11

1 reference

Europe PubMed Central

12 August 2017

Ballesta AM

12

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 October 1996

1 reference

Europe PubMed Central

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

12 August 2017

74

1 reference

Europe PubMed Central

12 August 2017

1126-1131

1 reference

Europe PubMed Central

12 August 2017

7

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1996.501

0 references

Circulating CA 15-3 antigen levels in non-mammary malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

2 October 2017

Mathematical models of drug resistance and chemotherapy effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

2 October 2017

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

2 October 2017

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

2 October 2017

MCA in patients with breast cancer: correlation with CEA and CA15-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

2 July 2018

The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

2 July 2018

The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077122

23 September 2018

Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for metastases in breast cancer: an assessment of biochemical and physical methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour markers in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor markers in chronic renal failure and hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB-2 protein in the sera of breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8855986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1996.501

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36141019&oldid=1520896488"